Neurocrine Biosciences, Inc. is a product-based biopharmaceutical company focused on neurologic and endocrine diseases and disorders. The Company's product candidates address pharmaceutical markets such as insomnia, anxiety, depression, cancer and diabetes. The Company's product candidates include gamma amino-butyric acid (GABA)-A Agonist, Corticotropin-Releasing Factor, IL-4 Fusion Toxin, Altered Peptide Ligands and Gonadotropin-Releasing Hormone Receptor.